new warnings, again, about using inhaled long-acting beta-agonists (Serevent, etc) for asthma

Please see the FDA's new recommendations for the use of long-acting beta agonists

You'll see new warnings, again, about using inhaled long-acting beta-agonists (Serevent, etc) for asthma.

These drugs already have a black box warning about a possible increased risk of severe asthma attacks and death.

Too many patients are still using long-acting beta-agonists ALONE for asthma...instead of with an inhaled corticosteroid.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote